Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Gene ; 526(2): 347-55, 2013 Sep 10.
Artigo em Inglês | MEDLINE | ID: mdl-23764561

RESUMO

We investigated the mutation spectrum of the phenylalanine hydroxylase gene (PAH) in a cohort of patients from 135 Slovak PKU families. Mutational screening of the known coding region, including conventional intron splice sites, was performed using high-resolution melting analysis, with subsequent sequencing analysis of the samples showing deviated melting profiles compared to control samples. The PAH gene was also screened for deletions and duplications using MLPA analysis. Forty-eight different disease causing mutations were identified in our patient group, including 30 missense, 8 splicing, 7 nonsense, 2 large deletions and 1 small deletion with frameshift; giving a detection rate of 97.6%. The most prevalent mutation was the p.R408W, occurring in 47% of all alleles, which concurs with results from neighboring and other Slavic countries. Other frequent mutations were: p.R158Q (5.3%), IVS12+1G>A (5.3%), p.R252W (5.1%), p.R261Q (3.9%) and p.A403V (3.6%). We also identified three novel missense mutations: p.F233I, p.R270I, p.F331S and one novel variant: c.-30A>T in the proximal part of the PAH gene promoter. A spectrum of 84 different genotypes was observed and a genotype based predictions of BH4-responsiveness were assessed. Among all genotypes, 36 were predicted to be BH4-responsive represented by 51 PKU families. In addition, genotype-phenotype correlations were performed.


Assuntos
Mutação , Fenilalanina Hidroxilase/genética , Fenilcetonúrias/genética , População Branca/genética , Alelos , Sequência de Bases , Biopterinas/análogos & derivados , Biopterinas/uso terapêutico , Pontos de Quebra do Cromossomo , Deleção de Genes , Frequência do Gene , Estudos de Associação Genética , Genótipo , Humanos , Taxa de Mutação , Fenilalanina Hidroxilase/metabolismo , Fenilcetonúrias/diagnóstico , Fenilcetonúrias/tratamento farmacológico , Prognóstico , Eslováquia , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA